Nicolas Ketterer

Nicolas Ketterer

UNVERIFIED PROFILE

Are you Nicolas Ketterer?   Register this Author

Register author
Nicolas Ketterer

Nicolas Ketterer

Publications by authors named "Nicolas Ketterer"

Are you Nicolas Ketterer?   Register this Author

43Publications

1426Reads

34Profile Views

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.

J Clin Oncol 2018 06 19;36(16):1603-1610. Epub 2018 Apr 19.

Matthew J. Maurer, Thomas M. Habermann, Carrie A. Thompson, Cristine Allmer, Patrick B. Johnston, Ivana N. Micallef, David J. Inwards, William R. Macon, Andrew L. Feldman, Susan L. Slager, Stephen M. Ansell, James R. Cerhan, Thomas E. Witzig, and Grzegorz S. Nowakowski, Mayo Clinic, Rochester, MN; Hervé Ghesquières and Gilles A. Salles, Université Claude Bernard, Lyon; Jean-Philippe Jais, Richard Delarue, Thierry J. Molina, Hopital Necker, Paris; Corinne Haioun, Groupe Hospitalier Mondor, Créteil; Frederic Peyrade, Centre Antoine Lacassagne, Nice; Olivier Fitoussi, Polyclinique Bordeaux Nord-Aquitaine, Bordeaux; Hervé Tilly, Centre de lutte Contre le Cancer Henri Becquerel, Rouen, France; Brian K. Link, Umar Farooq, Sergei Syrbu, and George J. Weiner, University of Iowa, Iowa City, IA; and Nicolas Ketterer, Clinique Bois-Cerf, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.5198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978469PMC
June 2018

High-dose therapy and autologous hematopoietic stem cell transplant in T-cell lymphoma: a single center experience.

Leuk Lymphoma 2014 Aug 4;55(8):1827-31. Epub 2014 Feb 4.

Service and Central Laboratory of Hematology, University Hospital of Lausanne (CHUV) , Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.852666DOI Listing
August 2014

Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy.

J Clin Oncol 2014 Apr 18;32(10):1066-73. Epub 2014 Feb 18.

Matthew J. Maurer, Hervé Ghesquières, Thomas E. Witzig, Carrie A. Thompson, Ivana N. Micallef, William R. Macon, Paul J. Kurtin, Cristine Allmer, Susan L. Slager, Thomas M. Habermann, and James R. Cerhan, Mayo Clinic, Rochester, MN; Hervé Ghesquières and Emmanuelle Nicolas-Virelizier, Centre Léon Bérard; Hervé Ghesquières and Gilles Salles, Université Claude Bernard, Unite Mixte de Recherche (UMR), Centre National de la Recherche Scientifique 5239, Lyon; Jean-Philippe Jais, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR S 872, Necker Hospital, Assistance Publique-Hopitaux de Paris; Richard Delarue, Necker Hospital; Thierry Jo Molina, Paris Descartes University, Paris Centre University Hospital, Paris; Corinne Haioun, Henri Mondor Hospital, Université Paris-Est, Créteil; Frédéric Peyrade, Centre Antoine Lacassagne, Nice; Olivier Fitoussi, Polyclinique Bordeaux-Nord, Bordeaux; Gilles Salles, Hospices Civils de Lyon, Pierre Benite; Hervé Tilly, INSERM U918, Institute for Research and Innovation in Biomedicine, Centre Henri Becquerel, Rouen, France; Nicolas Ketterer, Lausanne Hospital, Lausanne, Switzerland; and Sergei I. Syrbu and Brian K. Link, University of Iowa College of Medicine, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.5866DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965261PMC
April 2014

An unusual uterine tumor with signet ring cell features.

Int J Gynecol Pathol 2012 May;31(3):236-41

Institute of Pathology, Multidisciplinary Oncology Centre, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0b013e31823b6f6aDOI Listing
May 2012

Home care--a safe and attractive alternative to inpatient administration of intensive chemotherapies.

Support Care Cancer 2012 Mar 8;20(3):575-81. Epub 2011 Mar 8.

Centre Pluridisciplinaire d'Oncologie, University Hospital-CHUV, BH06 Rue du Bugnon 46, 1011 Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-011-1125-9DOI Listing
March 2012

Diagnosis and treatment of follicular lymphoma.

Swiss Med Wkly 2011 4;141:w13247. Epub 2011 Aug 4.

Onkologie/Hämatologie, Kantonsspital St. Gallen, Rorschacherstrasse, 9000 St. Gallen, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4414/smw.2011.13247DOI Listing
December 2011

Follicular lymphoma at relapse after rituximab containing regimens: comparison of time to event intervals prior to and after 90 Y-ibritumomab-tiuxetan.

Hematol Oncol 2011 Sep 22;29(3):131-8. Epub 2010 Sep 22.

Department of Nuclear Medicine, Sant'Andrea Hospital, University La Sapienza of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hon.968
Publisher Site
http://dx.doi.org/10.1002/hon.968DOI Listing
September 2011

Six of 12 relapsed or refractory indolent lymphoma patients treated 10 years ago with 131I-tositumomab remain in complete remission.

J Nucl Med 2011 Jun 13;52(6):896-900. Epub 2011 May 13.

Department of Nuclear Medicine, University Hospital of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.111.087460DOI Listing
June 2011

Radiolabeled and native antibodies and the prospect of cure of follicular lymphoma.

Oncologist 2008 Jun;13(6):657-67

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2008-0020DOI Listing
June 2008

[Radioimmunotherapy of follicular lymphoma: a step towards cure?].

Bull Cancer 2007 Sep;94(9):799-806

Multidisciplinary Oncology Center, University Hospital of Lausanne, CHUV, BH-06, 1011 Lausanne, Switzerland.

View Article

Download full-text PDF

Source
September 2007

Case study of intracerebral plasmacytoma as an initial presentation of multiple myeloma.

Neuro Oncol 2007 Jul 23;9(3):370-2. Epub 2007 May 23.

Department of Oncology, University Hospital CHUV , Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1215/15228517-2007-008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1907416PMC
July 2007

[Multiple myeloma].

Rev Med Suisse 2007 Mar;3(102):695-700

Service d'hématologie, CHUV, 1011 Lausanne.

View Article

Download full-text PDF

Source
March 2007

Repeated injections of 131I-rituximab show patient-specific stable biodistribution and tissue kinetics.

Eur J Nucl Med Mol Imaging 2005 Aug 12;32(8):943-51. Epub 2005 Apr 12.

Service of Nuclear Medicine, University Hospital of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-005-1798-8DOI Listing
August 2005

Primary intracranial dural lymphoma of mucosa-associated lymphoid tissue (MALT) type: report of one case and review of the literature.

Bull Cancer 2005 Jul;92(7):E51-6

Department of Oncology and Haematology, Pluridisciplinary Center for Oncology, CHUV, BH-06, 1011 Lausanne, Switzerland.

View Article

Download full-text PDF

Source
July 2005